Kolexia
Dufayard Jacqueline
Médecine générale
Hôpital De l'Archet
Nice, France
36 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Démence associée au SIDA Hépatite C Hépatite Co-infection Séropositivité VIH Hépatite B chronique Maladie chronique Hépatite B

Industries

ViiV Healthcare
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Raltegravir Inclusion Decreases CD4 T-Cells Intra-Cellular Viral Load and Increases CD4 and CD28 Positive T-Cells in Selected HIV Patients.
Cells   08 janvier 2022
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
The Journal of antimicrobial chemotherapy   22 octobre 2019
Selection of the R263K mutation to dolutegravir in cerebrospinal fluid HIV-1 virus in one patient with HIV-associated neurocognitive disorders.
AIDS (London, England)   06 novembre 2018
Is active hepatitis C associated with the size of HIV reservoir in successfully treated patients?
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   27 septembre 2018
Active hepatitis C is associated with a larger HIV reservoir in successfully treated patients
Abstracts of the 2018 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018 Marseille, France   01 mai 2018
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology   08 janvier 2018
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
The Journal of antimicrobial chemotherapy   07 novembre 2017
Erratum to 'HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)'.
Heliyon   16 mars 2017
HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).
Heliyon   13 février 2017
A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Journal of neurovirology   04 novembre 2016